2019
Unified Approaches to Surgery and Systemic Therapy for Renal Cell Carcinoma
Abello A, Kenney P. Unified Approaches to Surgery and Systemic Therapy for Renal Cell Carcinoma. 2019, 411-435. DOI: 10.1007/978-3-030-24378-4_24.Peer-Reviewed Original ResearchRenal cell carcinomaSystemic therapyCell carcinomaMetastatic renal cell carcinomaDisease-free survivalHigh-risk subsetVenous tumor thrombusTyrosine kinase inhibitorsAdjuvant settingCytoreductive nephrectomyUnresectable diseaseAdjuvant therapyAdvanced diseaseNeoadjuvant therapyOverall survivalTumor thrombusGenitourinary malignanciesPartial nephrectomySignificant causeTherapyEffective agentNephrectomyMonoclonal antibodiesKinase inhibitorsDisease
2012
Nodal disease in the setting of metastatic renal cell carcionoma: Can a lymph node dissection alter outcomes?
Chapin B, Delacroix S, Kenney P, Nogueras Gonzalez G, Tamboli P, Jonasch E, Tannir N, Wood C. Nodal disease in the setting of metastatic renal cell carcionoma: Can a lymph node dissection alter outcomes? Journal Of Clinical Oncology 2012, 30: 386-386. DOI: 10.1200/jco.2012.30.5_suppl.386.Peer-Reviewed Original ResearchLymph node dissectionMetastatic renal cell carcinomaCytoreductive nephrectomyOverall survivalCN0 patientsNodal diseasePN0 patientsWorse OSCox proportional hazards regressionClinical node statusTargeted therapy eraMedian overall survivalPost-operative complicationsWorse median OSProportional hazards regressionRenal cell carcinomaLong-axis diameterImproved OSMedian OSTherapy eraNode dissectionClavien systemLN statusPositive diseaseComplete resection